NCT05844644View on ClinicalTrials.gov

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

January 31, 2025

Conditions
Type 2 DiabetesObeseOverweightPrediabetes
Interventions
DIETARY_SUPPLEMENT

Release

One capsule of Release will be taken three times per day for 180 days in combination with the G4LP.

Trial Locations (2)

N9H 1S4

RECRUITING

One Retreat Wellness, LaSalle

N6B 3L1

RECRUITING

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Golo

INDUSTRY